Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Lionel Resnick0
David Binninger0
Herbert Weissbach0
Date of Patent
January 22, 2013
0Patent Application Number
125570220
Date Filed
September 10, 2009
0Patent Primary Examiner
Patent abstract
The NSAID, sulindac and/or its metabolites and derivatives, in combination with an agent that generates or induces reactive oxygen species (ROS), significantly enhances the killing of abnormal cells but does not affect normal cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against the abnormal cells.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
